Anthony T. LoSasso, Ge Bai, and Lawton Robert Burns argue that critics of private equity’s involvement in healthcare ignore that it is often the only financial lifeline available to distressed healthcare providers and can introduce an improvement in outcomes, including quality of care.
Theodosia Stavroulaki reviews how the involvement of private equity in American healthcare leads to, among other negative outcomes, burnout and stress among healthcare workers, particularly physicians. She writes that the consequences could cripple America’s healthcare system.
Robert I. Field argues that private equity’s impact on price competition among nursing homes is limited because prices are mostly determined by Medicaid. However, private equity does impact quality and labor outcomes, which deserve greater government scrutiny.
Brent Fulton discusses private equity’s investments in hospitals and assesses the risks it presents to key stakeholders: private equity investors, debt investors, patients, and the government. He argues financial transparency regulation is needed so fraudulent transfer and bankruptcy laws can be enforced to reduce uncompensated risk being borne by patients and the government (ultimately taxpayers).
Melissa Newham reviews how investors can alter the incentives and behavior of pharmaceutical companies to reduce competition and consumer welfare through common ownership and “rollup” deals.
Over the last year, the United States government has demonstrated increased concern about private equity’s involvement in health care. Barak Richman and Richard Scheffler...
Michelle Meagher writes that to preserve its contributions to the marketplace of ideas about antitrust, the Neo-Brandeisian movement must build out an infrastructure that archives its ideas and makes them accessible to the public. It must also continue to make its case for its core contributions to this marketplace, including on bigness and per se rules.
John B. Kirkwood writes that the future of Neo-Brandeisian movement must focus on three fronts: refining its approach to the consumer welfare standard, which it initially rejected but then used when in power; continuing to influence the monopolization cases against Big Tech and the Federal Trade Commission’s non-compete rule; and configuring the principles to govern competition in the economy’s next great tech frontier: artificial intelligence.
William Lazonick writes that recent United States industrial policy initiatives miss the centrality of corporate resource allocation for creating a robust economy, characterized by...
Taiwan has a history of implementing industrial policies to successfully encourage the development of internationally competitive high-tech firms. However, the new administration’s efforts to reorient industrial policy to achieve Taiwan’s commercial-cum-defense goal risks harming its economic resiliency.